Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunactivation in chronic heart failure. Inflammatory mediators].

S Genth-Zotz1, S von Haehling, S Blankenberg

  • 1II. Medizinische Klinik und Poliklinik, Johannes-Gutenberg-Universität Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. genth@2-med.klinik.uni-mainz.de

Zeitschrift Fur Kardiologie
|April 16, 2004
PubMed
Summary

Tumor necrosis factor-alpha (TNF) plays a role in chronic heart failure (CHF) progression. While direct TNF antagonism showed disappointing results, it may still benefit patients with systemic immune activation, especially during exacerbations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum TIMP-1 concentrations are associated with cancer incidence and cancer-related mortality in a population-based cohort.

Scientific reports·2026
Same author

Periodontal Health and Outcome of Atherosclerotic Disease in the Hamburg City Health Study.

Journal of dental research·2025
Same author

Feature tracking cardiovascular magnetic resonance reveals recovery of atrial function after acute myocarditis.

The international journal of cardiovascular imaging·2023
Same author

Symptom burden, psychosocial distress and palliative care needs in heart failure - A cross-sectional explorative pilot study.

Clinical research in cardiology : official journal of the German Cardiac Society·2022
Same author

Early results of a real-world series with two transapical transcatheter mitral valve replacement devices.

Clinical research in cardiology : official journal of the German Cardiac Society·2020
Same author

[Tumor effects on the heart and circulation].

Der Internist·2020

Area of Science:

  • Cardiology
  • Immunology
  • Biochemistry

Context:

  • Chronic heart failure (CHF) involves inflammatory processes.
  • Tumor necrosis factor-alpha (TNF) is notably activated in CHF patients.
  • Elevated TNF and related markers correlate with poor prognosis.

Purpose:

  • To review the role of TNF in chronic heart failure.
  • To evaluate the efficacy of TNF antagonism as a therapeutic strategy in CHF.
  • To identify patient subgroups who might benefit from TNF-targeted therapies.

Summary:

  • Inflammatory cytokines, particularly TNF, contribute to CHF development and progression.
  • Circulating levels of TNF, soluble TNF receptors (sTNFR1, sTNFR2), and interleukin-6 (IL-6) are significant prognostic indicators in CHF.

Related Experiment Videos

  • Two randomized trials targeting TNF directly in CHF patients yielded disappointing outcomes.

    • Impact:

    • Despite trial results, TNF antagonism remains a potential therapeutic avenue for specific CHF patient populations.
    • Focusing TNF antagonism on patients with systemic immune activation, especially during exacerbations, may improve outcomes.
    • Further research is needed to refine patient selection for TNF-targeted therapies in CHF.